The event focuses on the topic of Antibody-Drug Conjugate and brings together six companies with leading technologies in the field of biomedicine to pitch their business solutions while seeking funding opportunities and industry partnerships.<\/p>\n
Event Details<\/strong><\/p>\n Date & Time: Venue: Presented through Zoom. Attendees: 6 startups, 50+investors from Q Bay global network, invited speakers, guests, and partners.<\/p>\n At the beginning of the event, there will be a 40-min round table discussion focusing on \u201cHow to Maximize the Clinical Therapeutic Window of Antibody-drug Conjugates.\u201d Four panelists, from the bio-science industry, will give their insights into the industry. Our panelists include:<\/p>\n 1. Subhash Chauhan, Ph.D.: Professor and Chairman in the School of Medicine at University of Texas Rio Grande Valley Six companies will deliver their business pitch in order.<\/p>\n 1. Akelos is developing a first-in-class and novel mechanism of action drugs specifically for the treatment of neuropathic pain. This is a great chance for both start-ups and investors in the health care industry to seek developing opportunities and enhance industrial connections.<\/p>\n","protected":false},"excerpt":{"rendered":" virtual
\n6:30pm-9:00pm, May 20 (PDT)
\n9:30pm-12:00pm, May 20 (EDT)
\n9:30am-12:00am, May 21 (GMT+8, Beijing)<\/p>\n
\nOR join us on-site at Q Bay Center (160 E Tasman Dr, San Jose, CA 95134), PPE provided.<\/p>\n
\n2. Peng Guo, Ph.D.: Distinguished researcher and doctoral supervisor of Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences (CAS).
\n3. Jun Wang, Ph.D.: Co-founder & CSO of Lynk Pharmaceutical (Hangzhou) Co., Ltd
\n4. Ziping Wei, Ph.D.: Chief Executive Officer at Bliss Biopharmaceutical Co., Ltd.<\/p>\n
\n2. Lena Biosciences helps to save people\u2019s lives by identifying which cancer drugs work best for their particular cancer.
\n3. OneThree Biotech redesigns Drug Discovery with Biology-Driven AI which identifies safe and effective targets and links targets to potential treatments.
\n4. Amytrx Therapeutics advance a new class of peptide therapies to empower the body’s natural intracellular regulatory mechanisms to control inflammation and metabolic disease.
\n5. Nilogen Oncosystems develops the 3D-EXplore, a solution to power translational oncology that helps the drug development process.
\n6. Nordic Nanovector is a clinical-stage biopharmaceutical company dedicated to extending and improving the lives of patients with hematological cancers by developing and commercializing innovative targeted radio immunotherapies.<\/p>\n
\nEvent Ended<\/p>\n","protected":false},"author":1,"featured_media":252,"template":"","meta":{"_EventAllDay":false,"_EventTimezone":"America\/Los_Angeles","_EventStartDate":"2021-05-20 18:30:00","_EventEndDate":"2021-05-20 21:00:00","_EventStartDateUTC":"2021-05-21 01:30:00","_EventEndDateUTC":"2021-05-21 04:00:00","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"prefix","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[208],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_tribe_events_status":"","_tribe_events_status_reason":"","footnotes":""},"tags":[],"tribe_events_cat":[10],"class_list":["post-251","tribe_events","type-tribe_events","status-publish","has-post-thumbnail","hentry","tribe_events_cat-global-pitch-day","cat_global-pitch-day"],"_links":{"self":[{"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/tribe_events\/251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":3,"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/tribe_events\/251\/revisions"}],"predecessor-version":[{"id":625,"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/tribe_events\/251\/revisions\/625"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/media\/252"}],"wp:attachment":[{"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/media?parent=251"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/tags?post=251"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/flamingodesign.us\/QBay\/wp-json\/wp\/v2\/tribe_events_cat?post=251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}